Gender	Male
E-mail	waleed.hassen@mssm.edu
	waleed.hassen@mountsinai.org
Awards	Alpha Omega Alpha
	2000 Pfizer Scholar in Urology
	1999 Annual F. Valentine Resident essay contest, New York, NY
	1994 American Foundation for Urologic Disease Summer Student Research Fellowship

Waleed A. Hassen, M.D., has been appointed Assistant Professor in Urology. Specializing in minimally invasive urologic oncology procedures, Dr. Hassen received his medical degree from Eastern Virginia Medical School and then completed his residency at Mount Sinai. He also completed two fellowships at Memorial Sloan-Kettering Cancer Center, one in urologic oncology and another in minimally invasive surgery, specializing in urologic procedures such as laparoscopic radical prostatectomies and laparoscopic nephrectomies. His research and clinical interests focus on prostate and kidney cancers.

New topic

Gene Therapy

New topic

Prostate Cancer

Renal Cancer

 

New topic
Laparoscopic Surgery

Lazendorf SE, Hassen WA. Cytoplasmic sperm injection. Seminars in Reproductive Endocrinology 1993; 11: 95-100.

Toth TL, Lanzendorf SE, Sandow BA, Veeck LL, Hassen WA, Hansen K, Hodgen GD. Cryopreservation of human prophase I oocytes collected from unstimulated follicles. Fertility and Sterility 1994; 61: 1077-1082.

Lynch DF, Hassen W, Clements MA, Schellhammer PF, Wright GL. Serum levels of endothelial and neural cell adhesion molecules in prostate cancer. Prostate 1997; 32: 214-220.

Landman J, Lento P, Hassen W, Unger P, Waterhouse R. Feasibility of pathological evaluation of morcellated kidneys after radical nephrectomies. J Urol 2000; 164: 2086-2089.

Hassen W, Droller MJ. Current concepts in assessment and treatment of bladder cancer. Curr Opin. Urol 2000; 10: 291-299.

Hassen W, Sanford MA, Woo SC, Chen SH, Hall SJ. prospects for HSV-TK and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer. World J Urol 2000; 18: 130-135.

Sanford MA, Yan Y, Hassen W, Selleck WA, Atkinson G, Chen SH, Hall SJ. Independent contributions of gr-1+leukocytes and fas/fasl interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer. Hum Gene Ther 2001; 12: 1485-1498.

Hall SJ, Canfield SE, Yan Y, Hassen W, Selleck WA, Chen SH. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer. Gene Ther 2002 Apr; 9(8): 511-512.